Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Marie Imbert

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Bulletin Du Cancer|August 13, 2011
[New molecular targets and new clinical practices for hematopoietic stem cell mobilization]Christian Chabannon, Boris Calmels, Sarah Habibi, et al.
Blood|July 11, 2006
CD99 expressed on human mobilized peripheral blood CD34+ cells is involved in transendothelial migrationAnne-Marie Imbert, Ghania Belaaloui, Florence Bardin, et al.
Plos One|September 7, 2012
CD146 expression in human breast cancer cell lines induces phenotypic and functional changes observed in Epithelial to Mesenchymal TransitionAnne-Marie Imbert, Celine Garulli, Elodie Choquet, et al.
Breast Cancer Research : BCR|January 7, 2009
CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell linesGwladys Zabouo, Anne-Marie Imbert, Jocelyne Jacquemier, et al.
Blood|March 5, 2016
PLZF mutation alters mouse hematopoietic stem cell function and cell cycle progressionChristelle Vincent-Fabert, Nadine Platet, Amelle Vandevelde, et al.
The Journal of Experimental Medicine|May 12, 2004
DNAM-1 and PVR regulate monocyte migration through endothelial junctionsNicolas Reymond, Anne-Marie Imbert, Elisabeth Devilard, et al.
Plos One|March 6, 2020
Analysis of a large single institution cohort of related donors fails to detect a relation between SDF1/CXCR4 or VCAM/VLA4 genetic polymorphisms and the level of hematopoietic progenitor cell mobilization in response to G-CSFSylvain Garciaz, Patrick Sfumato, Angela Granata, et al.
Experimental Hematology|February 2, 2002
Transient detection of beta-galactosidase activity in hematopoietic cells, following reinjection of retrovirally marked autologous blood progenitors in patients with breast or ovarian cancer receiving high-dose chemotherapyClaude Bagnis, Christian Chabannon, Gwenaelle Gravis, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Bulletin Du Cancer|August 13, 2011
[New molecular targets and new clinical practices for hematopoietic stem cell mobilization]Christian Chabannon, Boris Calmels, Sarah Habibi, et al.
Blood|July 11, 2006
CD99 expressed on human mobilized peripheral blood CD34+ cells is involved in transendothelial migrationAnne-Marie Imbert, Ghania Belaaloui, Florence Bardin, et al.
Plos One|September 7, 2012
CD146 expression in human breast cancer cell lines induces phenotypic and functional changes observed in Epithelial to Mesenchymal TransitionAnne-Marie Imbert, Celine Garulli, Elodie Choquet, et al.
Breast Cancer Research : BCR|January 7, 2009
CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell linesGwladys Zabouo, Anne-Marie Imbert, Jocelyne Jacquemier, et al.
Blood|March 5, 2016
PLZF mutation alters mouse hematopoietic stem cell function and cell cycle progressionChristelle Vincent-Fabert, Nadine Platet, Amelle Vandevelde, et al.
The Journal of Experimental Medicine|May 12, 2004
DNAM-1 and PVR regulate monocyte migration through endothelial junctionsNicolas Reymond, Anne-Marie Imbert, Elisabeth Devilard, et al.
Plos One|March 6, 2020
Analysis of a large single institution cohort of related donors fails to detect a relation between SDF1/CXCR4 or VCAM/VLA4 genetic polymorphisms and the level of hematopoietic progenitor cell mobilization in response to G-CSFSylvain Garciaz, Patrick Sfumato, Angela Granata, et al.
Experimental Hematology|February 2, 2002
Transient detection of beta-galactosidase activity in hematopoietic cells, following reinjection of retrovirally marked autologous blood progenitors in patients with breast or ovarian cancer receiving high-dose chemotherapyClaude Bagnis, Christian Chabannon, Gwenaelle Gravis, et al.
Pageof 1